ABL Bio Market Cap

ABL Bio has a market cap or net worth of 7.80 trillion as of April 28, 2026. Its market cap has increased by 387.36% in one year.

Market Cap

7.80T

Enterprise Value

7.75T

Revenue

79.35B

Ranking

n/a

PE Ratio

n/a

Stock Price

140,300.00

Market Cap Chart

Since December 19, 2018, ABL Bio's market cap has increased from 608.61B to 7.80T, an increase of 1,182.37%. That is a compound annual growth rate of 41.42%.

Market Cap History

Date	Market Cap	% Change
Apr 28, 2026	7,804.65B	-29.21%
Dec 30, 2025	11.03T	663.70%
Dec 30, 2024	1,443.63B	22.53%
Dec 28, 2023	1,178.16B	7.19%
Dec 29, 2022	1,099.13B	5.54%
Dec 30, 2021	1,041.42B	-27.59%
Dec 30, 2020	Pro	Pro
Dec 30, 2019	Pro	Pro
Dec 28, 2018	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Samsung Biologics	70.73T
Celltrion	43.80T
ALTEOGEN	19.75T
Samsung Epis Holdings	14.28T
Sam Chun Dang Pharm.	9,570.62B
SK Biopharmaceuticals	8,011.45B
HLB Co., Ltd.	7,998.96B
LigaChem Biosciences	7,287.91B

Market Cap Rankings